Analyst Reco. Sotera Health Company

Equities

SHC

US83601L1026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
11.32 ^USD	+0.44%		+3.85%	-32.82%

Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ
Apr. 03	Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	Apr. 03	MT
Sotera Health Shares Rise Following Jefferies Upgrade	Mar. 25	MT
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target is $15.50	Mar. 25	MT
Barclays Adjusts Price Target on Sotera Health to $17 From $15, Maintains Overweight Rating	Jan. 25	MT
RBC Cuts Price Target on Sotera Health to $20 From $22, Keeps Outperform Rating	Nov. 02	MT
KeyBanc Adjusts Price Target on Sotera Health to $23 From $24, Maintains Overweight Rating	23-08-04	MT
RBC Raises Price Target on Sotera Health to $22 From $18, Keeps Outperform Rating	23-08-04	MT
Sotera Health Upgraded by KeyBanc to Overweight From Sector Weight Post Settlement of Ethylene Oxide Claims, Price Target Set at $24	23-06-26	MT
Barclays Adjusts Price Target on Sotera Health to $20 From $21, Maintains Overweight Rating	23-05-04	MT
RBC Cuts Price Target on Sotera Health to $18 From $19, Maintains Outperform Rating	23-05-04	MT
Barclays Adjusts Sotera Health Price Target to $21 From $22, Maintains Overweight Rating	23-04-04	MT
RBC Boosts Price Target on Sotera Health to $19 From $8, Maintains Outperform Rating	23-03-01	MT
JPMorgan Upgrades Sotera Health to Neutral From Underweight, Adjusts Price Target to $18 From $6	23-01-23	MT
Barclays Upgrades Sotera Health to Overweight From Underweight, Adjusts Price Target to $22 From $6	23-01-11	MT
Wolfe Research Upgrades Sotera Health to Outperform From Peer Perform, Price Target is $25	23-01-11	MT
Goldman Sachs Adjusts Sotera Health's Price Target to $8 From $9, Keeps Neutral Rating	22-11-23	MT
Barclays Downgrades Sotera Health Company to Underweight From Equalweight, Lowers Price Target to $6 From $7	22-11-15	MT
Barclays Trims Sotera Health Company's Price Target to $7 From $8, Maintains Equalweight Rating	22-11-03	MT
Citigroup Lowers Sotera Health Company's Price Target to $7 From $9, Maintains Neutral Rating	22-11-03	MT
Jefferies Lowers Sotera Health Company's Price Target to $7 From $21, Maintains Hold Rating	22-11-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Sotera Health Company

Equities

SHC

US83601L1026

Analyst Reco.

Filters